Intelligent Bio Solutions Inc. (INBS) stock is nearly perfect except the valuation

Intelligent Bio Solutions Inc. (NASDAQ: INBS) closed the day trading at $1.19 up 15.53% from the previous closing price of $1.03. In other words, the price has increased by $+0.1600 from its previous closing price. On the day, 30174670 shares were traded. INBS stock price reached its highest trading level at $1.4350 during the session, while it also had its lowest trading level at $1.0700.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



For a better understanding of INBS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.50 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 29.85 while its Price-to-Book (P/B) ratio in mrq is 3.40.

Stock Price History:

Over the past 52 weeks, INBS has reached a high of $1.60, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is 0.3326, while the 200-Day Moving Average is calculated to be 0.5507.

Shares Statistics:

Over the past 3-months, INBS traded about 2.44M shares per day on average, while over the past 10 days, INBS traded about 14.81M shares per day. A total of 14.89M shares are outstanding, with a floating share count of 14.74M. Insiders hold about 1.90% of the company’s shares, while institutions hold 1.90% stake in the company. Shares short for INBS as of Oct 13, 2022 were 151.86k with a Short Ratio of 0.11M, compared to 112.39k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.02% and a Short% of Float of 1.02%.

Earnings Estimates

Current recommendations for the stock of the company come from 0 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.31 and -$0.31 for the fiscal current year, implying an average EPS of -$0.31. EPS for the following year is -$0.09, with 1 analysts recommending between -$0.09 and -$0.09.